首页 / 院系成果 / 成果详情页

Acetylcytidine modification of DDX41 and ZNF746 by N-acetyltransferase 10 contributes to chemoresistance of melanoma  期刊论文  

  • 编号:
    E9CA722D63CD78190D610BE0DA9BAE93
  • 作者:
    Wang, Li#[1]Zeng, Yuefen#[2]Zhang, Ying[3];Zhu, Yun[2];Xu, Shuangyan[2];Liang, Zuohui*[2]
  • 语种:
    英文
  • 期刊:
    FRONTIERS IN ONCOLOGY ISSN:2234-943X 2024 年 14 卷 ; AUG 23
  • 收录:
  • 关键词:
  • 摘要:

    Background: Rapidly developed chemoresistance to dacarbazine (DTIC) is a major obstacle in the clinical management of melanoma; however, the roles and mechanisms of epi-transcriptomic RNA modification in this process have not been investigated. Method: DTIC-resistant (DR) melanoma cells were established for bulk RNA sequencing. The expressions of mRNAs were detected using qRT-PCR, and protein levels were determined using Western blotting and immunohistochemistry. Acetylated RNAs were detected by dot blotting and immunoprecipitation sequencing (acRIP-seq). A lung metastasis mouse model of melanoma was established to evaluate the anti-melanoma effects in vivo. Results: We identified that the expression of N-acetyltransferase 10 (NAT10), a catalytic enzyme for the N-4-acetylcytidine (ac4C) modification of RNA, was significantly upregulated in the DR cells. Clinically, NAT10 expression was elevated in disease progression samples and predicted a poor outcome. Using ac4C RNA immunoprecipitation (ac4C-RIP), we found that the mRNAs of two C2H2 zinc finger transcriptional factors, DDX41 and ZNF746, were targets of NAT10-mediated ac4C modification. Gain- and loss-of-function experiments in NAT10, or in DDX41 and ZNF746, altered the chemosensitivity of melanoma accordingly, and the two target genes also negatively correlated with clinical outcomes. Finally, pharmacological inhibition of NAT10 with Remodelin sensitized melanoma cells to DTIC treatment in vitro and in a mouse xenograft model. Conclusion: Our study elucidates the previously unrecognized role of NAT10-mediated ac4C modification in the chemoresistance of melanoma and provides a rationale for developing new strategies to overcome chemoresistance in melanoma patients.

  • 推荐引用方式
    GB/T 7714:
    Wang Li,Zeng Yuefen,Zhang Ying, et al. Acetylcytidine modification of DDX41 and ZNF746 by N-acetyltransferase 10 contributes to chemoresistance of melanoma [J].FRONTIERS IN ONCOLOGY,2024,14.
  • APA:
    Wang Li,Zeng Yuefen,Zhang Ying,Zhu Yun,&Liang Zuohui.(2024).Acetylcytidine modification of DDX41 and ZNF746 by N-acetyltransferase 10 contributes to chemoresistance of melanoma .FRONTIERS IN ONCOLOGY,14.
  • MLA:
    Wang Li, et al. "Acetylcytidine modification of DDX41 and ZNF746 by N-acetyltransferase 10 contributes to chemoresistance of melanoma" .FRONTIERS IN ONCOLOGY 14(2024).
  • 入库时间:
    9/24/2024 9:12:53 PM
  • 更新时间:
    10/13/2024 9:34:55 PM
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:28 下载次数:0
浏览次数:28
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部